Kalsifik Lezyonlarda Perkütan Koroner Girişim

Leopold JA. Vascular calcification: Mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med. 2014;25(4):267-74.

Reynolds JL, Joannides AJ, Skepper JN, et al. (2004). Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. Journal of the American Society of Nephrology, 15(11), 2857-2867.

Budoff MJ, Shaw LJ, Liu ST, et al. (2007). Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. Journal of the American College of Cardiology, 49(18), 1860-1870.

Brilakis ES, Best PJ, Elesber AA, et al. Incidence, retrieval methods, and outcomes of stent loss during percutaneous coronary intervention: a large single-center experience. Catheter Cardiovasc Interv. 2005 Nov;66(3):333-40.

Neves PO, Andrade J, Monção H, et al. (2017). Coronary artery calcium score: current status. Radiologia Brasileira. 2017 May-Jun; 50(3): 182–189.

Wang X, Matsumura M, Mintz GS, et al. Invivo calcium detection by comparing optical coherence tomography, intravascular ultrasound, and angiography. J Am Coll Cardiol. 2017;10: 869–79.

Hoffmann R, Mintz GS, Popma JJ, et al. Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. Eur Heart J 1998;19:1224–31. https://doi. org/10.1053/euhj.1998.1028; PMID: 9740344

Mehanna E, Bezerra HG, Prabhu D, et al. Volumetric characterization of human coronary calcification by frequency-domain optical coherence tomography. Circ J. 2013;77: 2334–40.

Wang X, Matsumura M, Mintz GS, et al. In Vivo Calcium Detection by Comparing Optical Coherence Tomography, Intravascular Ultrasound, and Angiography. JACC Cardiovasc Imaging. 2017 Aug;10(8):869-879.

Costopoulos C, Naganuma T, Colombo A, et al. Tools and techniques clinical: percutaneous intervention of calcific coronary lesions. EuroIntervention 2014;9:1124–6. https://doi. org/10.4244/EIJV9I9A188; PMID: 24457284.

Raja Y, Routledge HC, Doshi SN, et al. A non-compliant, high pressure balloon to manage undilatable coronary lesions. Catheter Cardiovasc Interv 2010;75:1067–73. https://doi. org/10.1002/ccd.22430; PMID: 20517970.

Secco GG, Ghione M, Mattesini A, et al. (2016). Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon. EuroIntervention, 12(3), 359-365.

Okura H, Hayase M, Shimodozono S, et al. Restenosis reduction by cutting balloon evaluation. Mechanisms of acute lumen gain following cutting balloon angioplasty in calcified and noncalcified lesions: an intravascular ultrasound study. Catheter Cardiovasc Interv 2002;57:429–36. https://doi. org/10.1002/ccd.10344; PMID: 12455075.

Jujo K, Saito K, Ishida I, et al. Intimal disruption affects drugeluting cobalt-chromium stent expansion: a randomized trial comparing scoring and conventional balloon predilation. Int J Cardiol 2016;221:23–31. https://doi.org/10.1016/j. ijcard.2016.07.002; PMID: 27400292.

Hansen D, Auth D, Vracko R, et al. Rotational atherectomy in atherosclerotic rabbit iliac arteries. Am Hear J. 1988;115:160–5.

Whitlow PL, Bass TA, Kipperman RM, et al. Result of the study to determine rotoblator and transluminal angioplasty strategy (STRATAS) .Am J Cardiol 2001;87:699-705.

Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. [Internet]. N Engl J Med. 2007 ;357:2001-15.

Koch KC, Vom Dahl J, Kleinhans E, et al. Influence of a platelet GPIIb/IIIa receptor antagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocardial Tc-99m Sestamibi scintigraphy. J Am Coll Cardiol. 1999;33:998–1004.

Chambers JW, Diage T. Evaluation of the Diamondback 360 coronary orbital atherectomy system for treating de novo, severely calcified lesions. Expert Rev Med Devices. 2014; 11:457–466.

Parikh K, Chandra P, Choksi N Khanna, et al. (2013). Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: the ORBIT I trial. Catheterization and Cardiovascular Interventions, 81(7), 1134-1139.

Chambers JW, Feldman RL, Himmelstein SI, et al. (2014). Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II). JACC: Cardiovascular Interventions, 7(5), 510-518.